GlassScriptPhysician profile
William Horvath
NPI 1902105521
$1,671.38
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,273 · 2022: $355 · 2023: $42.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $612.75 | 2021-2022 | |
| Janssen Biotech, INC. | $377.04 | 2021-2022 | |
| Boston Scientific Corporation | $152.78 | 2021 | |
| Myriad Genetic Laboratories, INC. | $107.61 | 2021 | |
| Olympus America INC. | $106.83 | 2021 | |
| Endo Pharmaceuticals INC. | $74.37 | 2021-2022 | |
| Clarus Therapeutics INC. | $64.75 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $56.38 | 2021 | |
| Axonics, INC. | $42.63 | 2023 | Axonics |
| Astellas Pharma US INC | $23.29 | 2021 | |
| Convatec INC. | $19.26 | 2022 | |
| Pfizer INC. | $18.20 | 2022 | |
| Coloplast Corp | $15.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Horvath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.